PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Transferring fewer embryos doesn't reduce delivery rates if linked to reimbursing 6 IVF cycles

2013-11-27
(Press-News.org) Contact information: Emma Mason
wordmason@mac.com
European Society of Human Reproduction and Embryology
Transferring fewer embryos doesn't reduce delivery rates if linked to reimbursing 6 IVF cycles Research from Belgium has shown that if governments legislate to restrict the numbers of embryos transferred during fertility treatment, but combine it with a policy of reimbursing six cycles of assisted reproduction technology (ART), there is no detrimental impact on pregnancy and delivery rates. However, there is a greatly reduced risk of multiple births, which have associated health risks for mother and babies and are an increased cost to the state.

A study, published online today (Wednesday) in Europe's leading reproductive medicine journal Human Reproduction [1], investigated delivery rates three years before and after Belgium introduced such a policy in July 2003. It found that there was no statistically significant difference in the probability of a woman giving birth to a healthy baby (or twins) – the cumulative delivery rate (CDR) – after the legislation came in to force. The cumulative delivery rate after six ART cycles or within 36 months of starting treatment was 60.8% for women treated after July 2003 and 65.6% for women treated before. Multiple pregnancy rates were halved as a result of the new legislation with twin delivery rates dropping from 24% to 12%.

While the effect on pregnancy and delivery rates of policies for transferring single embryos during fertility treatment have been investigated before, notably in Sweden, this Belgian study breaks new ground. The researchers say that governments worldwide should aim to follow a similar policy of coupling ART reimbursement with a reduction in the numbers of embryos transferred.

Dr Karen Peeraer, adjunct head of clinic at Leuven University Fertility Center, Leuven, Belgium, who led the research, said: "Our study is the first to calculate the cumulative delivery rate in a real-life scenario for up to six cycles or 36 months over a period of three years before and after the implementation of the Belgian legislation limiting the number of embryos transferred. It shows that ART can be made reimbursable for those who need it if governments couple reimbursement to an embryo transfer policy with the aim of maintaining high delivery rates and reducing multiple pregnancy rates, the main complication of ART treatment."

In their paper, the authors write: "The results of our paper have implications for public health policies worldwide with respect to quality, safety, regulation and financial control of treatments with ART. From a public health point of view the 'Belgian model' can now be considered by other governments for application worldwide. In countries without ART reimbursement, the Belgian model with restricted embryo transfer policy can be used to achieve at least a 50% reduction in MPR [multiple pregnancy rates] and associated public health costs, with no negative impact on the CDR per patient, quite relevant to patients who have to pay ART treatments themselves. The substantial amount of money saved by this policy can be used ideally to improve patient access to ART by selective reimbursement."

The researchers believe that introducing the Belgian policy may result in financial savings for governments through the reduction in multiple pregnancy rates. "Our next step is to perform a health-economic analysis to show that the reduction in multiple pregnancy rates results does indeed result in a financial benefit for the government, so that the refunding of six cycles is still a responsible policy," said Professor Thomas D'Hooghe, last author of the paper and head of the Leuven University Fertility Center.

The researchers embarked on the study in order to see whether the policy of transferring fewer embryos might have resulted in a reduction in the cumulative delivery rate. "Although it has already been shown that the legislation had no negative effect on pregnancy rates, a lower cumulative delivery rate might be expected compared with the situation before 2003," said Dr Peeraer.

The researchers compared delivery rates among 463 patients treated at the Leuven University Fertility Center between 1 July 1999 and 30 June 2002 with 795 patients treated at the Center between 1 July 2003 and 30 June 2006. The women were younger than 43 and they were followed until six ART cycles had been completed, or until a baby was born, or until discontinuation of treatment, or for 36 months.

Before the legislation, a maximum of two or three embryos were transferred. After the legislation, the laboratory costs [2] for up to six cycles of ART were funded by the state, but only if embryo transfer was restricted depending on the women's ages and the cycles. In patients younger than 36 years, only one embryo can be transferred in the first cycle, regardless of embryo quality. In the second cycle one embryo is transferred, but two can be transferred if they are poor quality. In the next four cycles, a maximum of two embryos can be transferred. For patients aged between 36-39 years, a maximum of two embryos can be transferred in the first two cycles, and maximum of three embryos can be transferred in the next four cycles. For patients older than 40, no legal limitation applies, but usually two or three embryos are transferred. Either fresh or frozen embryos were used in the six cycles.

The researchers looked at pessimistic, optimistic and realistic scenarios. In the realistic scenario, they included information on the quality of the embryos in order to get a more accurate prognosis for their patients.

In the realistic scenario, they found that cumulative delivery rates within 36 months were comparable (65.6% versus 60.8%) between women treated before and after 2003, as well as between the different age groups. After 2003, there was a lower cumulative delivery rate within the first two cycles, but no difference within the four subsequent cycles, so that when all six cycles were taken into account there was no statistically significant difference between the women treated before or after 2003. This also applied to all age groups.

Dr Peeraer said: "We found that among women treated after July 2003 there was a higher proportion of single embryo transfer cycles, a higher singleton delivery rate and a lower twin delivery rate (12% versus 24%) compared to women treated before that date."

Prof D'Hooghe concluded: "We hope that this study, together with results from Sweden, will convince other governments to couple ART reimbursement to strict embryo transfer policies."

### [1] "The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction technology", by K. Peeraer, S. Debrock, A. Laenen, P. De Loecker, C. Spiessens, D. De Neubourg, and T.M. D'Hooghe. Human Reproduction journal. doi:10.1093/humrep/det405. [2] Before 2003 laboratory costs varied from centre to centre in Belgium but were usually between €1,000-1,500 Euros per cycle. Medication costs are partially reimbursed by the state and patients still need to pay around €100 per cycle. Costs of blood tests and ultrasound monitoring are also partially reimbursed by the state and patients still need to pay approximately €100 per cycle. The policy on reimbursement (and costs) for medication, blood tests and ultrasounds is largely unchanged from before 2003.


ELSE PRESS RELEASES FROM THIS DATE:

Iron preserves, hides ancient tissues in fossilized remains

2013-11-27
Iron preserves, hides ancient tissues in fossilized remains New research from North Carolina State University shows that iron may play a role in preserving ancient tissues within dinosaur fossils, but also may hide them from detection. The finding could ...

Screening new inmates for HIV may not reveal many new undetected cases, study shows

2013-11-27
Screening new inmates for HIV may not reveal many new undetected cases, study shows CHAPEL HILL, N.C. – More than 90 percent of HIV-infected inmates entering prison in North Carolina had previously tested positive for the virus, according ...

Gratitude or guilt? People spend more when they 'pay it forward'

2013-11-27
Gratitude or guilt? People spend more when they 'pay it forward' UC Berkeley study finds we are more generous when covering the cost of others As shoppers across the nation prepare to pounce on Black Friday sales, researchers at UC Berkeley are looking ...

Finding hidden circles may improve social network privacy settings

2013-11-27
Finding hidden circles may improve social network privacy settings Creating a computer program to find relationships in networks, such as Google Plus and Facebook, may help users more easily set up and maintain privacy settings, according to researchers. "We want to help users ...

Inexpensive 'nano-camera' can operate at the speed of light

2013-11-27
Inexpensive 'nano-camera' can operate at the speed of light Device could be used in medical imaging, collision-avoidance detectors for cars, and interactive gaming CAMBRIDGE, Mass -- A $500 "nano-camera" that can operate at the speed of light has been developed ...

Drug reduces brain changes, motor deficits associated with Huntington's disease

2013-11-27
Drug reduces brain changes, motor deficits associated with Huntington's disease Animal study supports disease therapies that mimic the action of growth-promoting proteins in brain WASHINGTON, DC — A drug that acts like a growth-promoting protein in the brain ...

Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease

2013-11-27
Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease Discovery also reveals how a drug, now in multiple human trials, halts production of Myc protein and stops progression of AML Cold Spring Harbor, NY – A team of ...

Kessler stroke researchers explore five new avenues for rehabilitation research

2013-11-27
Kessler stroke researchers explore five new avenues for rehabilitation research Treatments based on behavioral or non-invasive physiological stimulation show greatest potential West Orange, NJ. November 26, 2013. Because the concept of permanent neurological ...

Health insurance increases preventive care but not risky behaviors

2013-11-27
Health insurance increases preventive care but not risky behaviors (SACRAMENTO, Calif.) -- People with health insurance are more likely to use preventive services such as flu shots and health screenings to reduce their risk of serious ...

National study finds donor age not a factor in most corneal transplants

2013-11-27
National study finds donor age not a factor in most corneal transplants (SACRAMENTO, Calif.) — Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, and ...

LAST 30 PRESS RELEASES:

Combination therapy could expand treatment options for AML patients, extend survival

Microscopic DNA ‘flowers’ could deliver medicine exactly where it’s needed

Hormone therapy alters body proteins to match gender identity

Eat, explore, rest: a leptin-sensing brain circuit helps overcome anxiety to meet vital needs

2D devices have hidden cavities that can modify electronic behavior

Experts urge risk-based monitoring as Barrett’s esophagus care moves beyond one-size-fits-all

How multiple sclerosis harms a brain long before symptoms appear

Did marine life in the palaeocene use a compass?

About 9 in 10 haven’t heard of condition that affects nearly 90% of U.S. adults

Personalized brain stimulation offers new hope for people with hard-to-treat epilepsy

The tiny droplets that bounce without bursting

Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

What is the extent of disparities in cancer clinical trials among low- and middle-income countries?

Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns

Nearly half of Finns with chronic conditions find medication therapy a burden

Do animals fall for optical illusions? What fish and birds can teach us about perception

New guideline emphasizes conversations about mood, mental health between patients and clinicians

Children’s Hospital of Philadelphia researchers observe significant reduction in diagnosis of food allergies following expert guidelines encouraging early peanut exposure

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy

Drug combo cuts risk of death in advanced prostate cancer by 40%

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

[Press-News.org] Transferring fewer embryos doesn't reduce delivery rates if linked to reimbursing 6 IVF cycles